Regression by differentiation in the Sinclair swine model of cutaneous melanoma

Melanoma Research

Volumn 7, Issue 6, 1997, Pages 471-477

  Greene, J F ^a   Morgan, C D ^b   Rao, A ^c   Amoss, M S ^b   Arguello, F ^d  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b University Health Science Center   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cancer therapy; Differentiation; Macrophage; Melanoma; Regression; Swine

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; CANCER THERAPY; CANCER TRANSPLANTATION; HISTOPATHOLOGY; MACROPHAGE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER; SWINE DISEASE; TUMOR DIFFERENTIATION;

ANIMALS; BISBENZIMIDE; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; HUMANS; MALE; MELANOMA; MICE; MICE, SCID; MICROSCOPY, ELECTRON; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM TRANSPLANTATION; PIGMENTATION; SKIN NEOPLASMS; STAINING AND LABELING; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031404270     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199712000-00005     Document Type: Article

References (34)

1. Greene JF Jr, TownsendJS IV, Amoss MS Histopathology of regression in Sinclair swine model of melanoma. Lab Invest 1994; 71: 17-24.
2. Das Gupta TK, Ronan SG, Beattie CW, Shilkaitis A, Amoss MS Comparative histopathology of porcine and human cutaneous melanoma. Pediatr Dennatol 1989; 6: 289-299.
3. Oxenhandler RW, Adelstein EH, Haigh JP, Hook RR Jr, Clark WH Malignant melanoma in the Sinclair miniature swine: an autopsy study of 60 cases. Am J Pathol 1979; 96: 707-720.
4. Clark WH What is inherited in neoplastic systems? Animal models of cutaneous malignant melanoma. Lab Invest 1994; 71: 1-4.
5. Oxenhandler RW, Berkelhammer J, Smith GD, Hook RR Growth and regression of cutaneous melanoma in Sinclair miniature swine. Am J Pathol 1982; 109: 259-269.
6. Cunha GR, Vanderslice KD. Identification in histological sections of species origin of cells from mouse, rat, and human. Stain Tecbnot 1984; 59: 7-12.
7. McGovern VJ. Spontaneous regression of melanoma. Pathology 1975; 7: 91-99-
8. Bodurtha AJ, Berkelhammer J, Kirn YH, Laucius JF, Mastrangelo MJ. A clinical, lustologic, and immunologie study of a case of metastatic malignant melanoma undergoing spontaneous remission. Cancer 1976; 37: 735-742.
9. Smith JL Jr, Stehlin JS Spontaneous regression of primary malignant melanomas with regional métastases. Cancer 1965; 18: 1399-1415.
10. Gromet MA, Epstein WL, Blois MS. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer 1978; 42: 2282-2292.
11. Ghadially FN. Ultrastntctiiral Pathology of the Cell and Matrix. Vol 2, 3rd edn. Boston: Butterworths, 1988: 798.
12. Mishima Y. Cellular and subcellular differentiation of melanin phagocytosis and synthesis by lysosomal and melanosomal activity. J Invest Dermatol 1966; 46: 70-75.
13. Hori Y, Toda K, Pathak MA, Clark WH Jr, Fitzpatrick TB. A fine-structure study of the human epidermal melanosome complex and its acid phosphatase activity. J Ultrastmct Res 1968; 25: 109-120.
14. Horikoshi T, Jimbow K, Sugiyama S. Comparison of macromelanosomes and autophagic giant melanosome complexes in nevocellular nevi, lentigo simplex, and malignant melanoma. / Cutaneous Pathol 1982; 9: 329-339.
15. Takahashi H, Parson PG. In-vitro phenotypic alteration of human melanoma cells induced by differentiating agents: heterogeneous effects on cellular growth and morphology, enzymatic activity, and antigenic expression. Pigment Cell Res 1990; 3: 223-232.
16. Winder AJ, Wittbjer A, Rosengren E, Rorsman H. The / mouse brown (b) locus protein has dopachrome tautomerase activity and is located in lysosomes in transfected fibroblasts. / Cell Sci 1993; 106: 153-166.
17. Schraermeyer U, Stieve H. A newly discovered pathway of melanin formation in cultured retinal pigment epithelium of cattle. Cell Tissue Res 1994; 276: 273-279.
18. Mishima Y. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulator)' factors. Pigment Cell Res 1994; 7: 376-387.
19. Diment S, Eidelman M, Rodriguez GM, Orlow SJ. Lysosomal hydrolases are present in melanosomes and are elevated in melanizing cells. / Biol Cbem 1995; 270:4213-4215.
20. Schraermeyer U. Transport of endocytosed material into melanin granules in cultured choroidal melanocytes of cattle - new insights into the relationship of melanosomes with lysosomes. Pigment Cell Res 1995; 8: 209-214.
21. Le Poole 1C, Van den Wijngaard RM, Westerhof W, Verkruisen RP, Dutrieux RP, Dingemans KP, Das PK. Phagocytosis by normal human melanocytes in vitro. Exp Cell Res 1993; 205: 388-395.
22. Kreider JV, Schmoyer ME. Spontaneous maturation and differentiation of B16 melanoma cells in culture. JNatl Cancer Inst 1975; 55: 641-647.
23. Houghton AN, Eisinger M, Albino AP, Cairncross JG, Old LJ. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J ExpMed 1982; 156: 1755-1766.
24. Giuffre L, Schreyer M, Mach J-P, Carrel S. Cyclic AMP induces differentiation in vitro of human melanoma cells. Cancer 1988; 1: 1132-1141.
25. Bennett DC. Mechanisms of differentiation in melanoma cells and melanocytes. Environ Health Perspect 1989; 80: 49-59.
26. Kolb CA, Mansfield JM. Effects of theophylline treatment on mouse B-16 melanoma cells in vitro. Oncology 1980; 37: 343-352.
27. Sato S, Takeuchi T. Cell type conversion in a mouse melanoma cell clone. In Vitro 1982; 18: 661-667.
28. Kreider JW, Wade DR, Rosenthal M, Densley T. Maturation and differentiation of B16 melanoma cells induced by theophylline treatment. / Natl Cancer Inst 1975; 54: 1457-1467.
29. Kiguchi K, Collart FR, Henning-Chubb C, Huberman E. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase; altered patterns of IMP dehydrogenase expression and activity. Cell Growth Differ 1990; 1: 259-270.
30. Jiang HP, lin J, Young SM, Goldstein NI, Waxman S, Davila V, Chellappan SP, Fisher PB. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate. Oncogene 1995; 11: 1179-1189.
31. Liu L, Shack S, Stetler-Stevenson WG, Hudgins WR, Samid D. Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate. / Invest Dennatol 1994; 103: 335-340.
32. Jiang J, Sharma SD, Nakamura S, Lai JY, FinkJL, Hruby VJ, Hadley ME. The Melanotropic peptide (Nle4, DPheT), alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation. Pigment Cell Res 1995; 8(6): 314-323-
33. Greene JF Jr, Alexander MA, Arguello F. Diphtheria toxin mediated differentiation in human melanoma xenografts. Mod Pathol 1997; 10: 45A, abstract 245.
34. Clark WH What is inherited in neoplastic systems? Animal models of cutaneous malignant melanoma. Lab Invest 1994; 71(1): 1-4 (editorial).